Urmăriți
Dionysios Chartoumpekis
Dionysios Chartoumpekis
Lausanne University Hospital (CHUV), Service of Endocrinology, Diabetology and Metabolism
Adresă de e-mail confirmată pe chuv.ch - Pagina de pornire
Titlu
Citat de
Citat de
Anul
Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21
DV Chartoumpekis, IG Habeos, PG Ziros, AI Psyrogiannis, ...
Molecular medicine 17, 736-740, 2011
2932011
EMT factors and metabolic pathways in cancer
I Georgakopoulos-Soares, DV Chartoumpekis, V Kyriazopoulou, ...
Frontiers in oncology 10, 499, 2020
2822020
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice
DV Chartoumpekis, A Zaravinos, PG Ziros, RP Iskrenova, AI Psyrogiannis, ...
PloS one 7 (4), e34872, 2012
2662012
Nrf2 represses FGF21 during long-term high-fat diet–induced obesity in mice
DV Chartoumpekis, PG Ziros, AI Psyrogiannis, AG Papavassiliou, ...
Diabetes 60 (10), 2465-2473, 2011
2022011
Notch-Nrf2 Axis: Regulation of Nrf2 Gene Expression and Cytoprotection by Notch Signaling
N Wakabayashi, JJ Skoko, DV Chartoumpekis, S Kimura, SL Slocum, ...
Molecular and cellular biology 34 (4), 653-663, 2014
1402014
New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome
D V Chartoumpekis, T W Kensler
Current diabetes reviews 9 (2), 137-145, 2013
1232013
Crosstalk between Nrf2 and Notch signaling
N Wakabayashi, DV Chartoumpekis, TW Kensler
Free Radical Biology and Medicine 88, 158-167, 2015
1122015
Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet
SL Slocum, JJ Skoko, N Wakabayashi, S Aja, M Yamamoto, TW Kensler, ...
Archives of biochemistry and biophysics 591, 57-65, 2016
992016
A bibliometric review of the Keap1/Nrf2 pathway and its related antioxidant compounds
A Paunkov, DV Chartoumpekis, PG Ziros, GP Sykiotis
Antioxidants 8 (9), 353, 2019
922019
Simvastatin activates Keap1/Nrf2 signaling in rat liver
IG Habeos, PG Ziros, D Chartoumpekis, A Psyrogiannis, V Kyriazopoulou, ...
Journal of Molecular Medicine 86, 1279-1285, 2008
922008
Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms
DL Palliyaguru, DV Chartoumpekis, N Wakabayashi, JJ Skoko, ...
Free Radical Biology and Medicine 101, 116-128, 2016
872016
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
DV Chartoumpekis, N Wakabayashi, TW Kensler
Biochemical Society Transactions 43 (4), 639-644, 2015
782015
Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway
D Chartoumpekis, PG Ziros, A Psyrogiannis, V Kyriazopoulou, ...
Biochemical and biophysical research communications 396 (2), 463-466, 2010
782010
Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice
BM Rush, CD Bondi, SD Stocker, KM Barry, SA Small, J Ong, S Jobbagy, ...
Kidney international 99 (1), 102-116, 2021
522021
Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice
DV Chartoumpekis, DL Palliyaguru, N Wakabayashi, M Fazzari, ...
American Journal of Physiology-Endocrinology and Metabolism 315 (2), E180-E195, 2018
502018
Broccoli sprout beverage is safe for thyroid hormonal and autoimmune status: Results of a 12-week randomized trial
DV Chartoumpekis, PG Ziros, JG Chen, JD Groopman, TW Kensler, ...
Food and chemical toxicology 126, 1-6, 2019
452019
Keap1/Nrf2 signaling: a new player in thyroid pathophysiology and thyroid cancer
CO Renaud, PG Ziros, DV Chartoumpekis, M Bongiovanni, GP Sykiotis
Frontiers in endocrinology 10, 510, 2019
422019
Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice
Y Yagishita, A Uruno, DV Chartoumpekis, TW Kensler, M Yamamoto
Journal of Endocrinology 240 (3), 403-416, 2019
412019
The Keap1/Nrf2 signaling pathway in the thyroid—2020 update
C Thanas, PG Ziros, DV Chartoumpekis, CO Renaud, GP Sykiotis
Antioxidants 9 (11), 1082, 2020
382020
Keap1 hypomorphism protects against ischemic and obstructive kidney disease
RJ Tan, DV Chartoumpekis, BM Rush, D Zhou, H Fu, TW Kensler, Y Liu
Scientific reports 6 (1), 36185, 2016
382016
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20